176 related articles for article (PubMed ID: 33429092)
1. Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass.
Schneider PA; Krievins DK; Halena G; Schmidt A; Lyden S; Lee V; Hu M; Adelman M
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1266-1272.e3. PubMed ID: 33429092
[TBL] [Abstract][Full Text] [Related]
2. Long term clinical and functional venous outcomes after endovascular transvenous femoro-popliteal bypass.
Rumba R; Krievins D; Savlovskis J; Ezite N; Kukulis I; Petrosina E; Mouttet L; Lacis A; Zarins CK
Int Angiol; 2022 Dec; 41(6):509-516. PubMed ID: 36194385
[TBL] [Abstract][Full Text] [Related]
3. One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass.
Krievins DK; Halena G; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Nair K; Holden A; Schmidt A
J Vasc Surg; 2020 Nov; 72(5):1648-1658.e2. PubMed ID: 32276015
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System.
Halena G; Krievins DK; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Schmidt A; Zdunek M; Lyden SP
J Endovasc Ther; 2022 Feb; 29(1):84-95. PubMed ID: 34465223
[TBL] [Abstract][Full Text] [Related]
5. The DETOUR procedure: no more need for conventional bypass surgery?
Krievins D; Savlovskis J; Ezite N; Hill A; Kisis K; Gedins M; Zellans E; Holden A
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):172-177. PubMed ID: 29327570
[TBL] [Abstract][Full Text] [Related]
6. DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.
Lyden SP; Soukas PA; De A; Tedder B; Bowman J; Mustapha JA; Armstrong EJ;
J Vasc Surg; 2024 Jun; 79(6):1420-1427.e2. PubMed ID: 38367850
[TBL] [Abstract][Full Text] [Related]
7. Endovascular Transvenous versus Open Femoropopliteal Bypass.
Rumba R; Krievins D; Ezite N; Lacis A; Mouttet L; Vavere AL; Zarins CK
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792960
[No Abstract] [Full Text] [Related]
8. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
10. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
12. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
13. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results.
Cvetanovski MV; Jovev S; Cvetanovska M; Blazevski B; Colanceski R; Andreevska T; Gramatnikovski N; Kartalov A
Prilozi; 2009 Jul; 30(1):105-18. PubMed ID: 19736534
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
16. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
19. Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass.
Rumba R; Krievins D; Savlovskis J; Ezite N; Lacis A; Petrosina E; Mouttet L; Gardovskis J; Zarins CK
Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984464
[No Abstract] [Full Text] [Related]
20. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
